Ribavirin, an antiviral drug used to treat Hepatitis C and certain viral hemorrhagic fevers, may have its efficacy influenced by genetic variations in the OASL gene, which is involved in the immune response against viruses through the interferon pathway. This interaction between OASL gene variations and ribavirin is pharmacodynamic, impacting how the drug affects the body and the body's response to these effects.